ABVC BioPharma CEO Highlights Breakthrough Antidepressant on Global Stage
June 26, 2025 — ABVC BioPharma's CEO discusses ABV-1504, a groundbreaking antidepressant without suicidal ideation side effects, on Biotech Orbit podcast. A potential game-changer for MDD treatment.